首页> 外文期刊>Journal of cataract and refractive surgery >Endothelial cell loss after pIOL implantation for high myopia
【24h】

Endothelial cell loss after pIOL implantation for high myopia

机译:高度近视pIOL植入后内皮细胞丢失

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Coullet et al. report 2 cases of severe endothelial cell loss 2 years after angle-supported phakic intraocular lens (pIOL) implantation. The first patient was 47 years old at the time of implantation and the second, 52 years old. Furthermore, in the second case, the preoperative endothelial cell count (ECC) was 2000 cells/mm~2, which is the lower limit for implantation with most types of pIOLs.The proportion of refractive surgery peformed by lenticular methods is increasing. The surgeon must advise the patient about the risks and benefits of preserving the crystalline lens by implanting a pIOL versus the alternative of refractive lens exchange (RLE) and placement of an IOL. In the second scenario, a further discussion ensues regarding the various IOL options with respect to pseudoaccommodation, multifocality, and adverse visual effects.
机译:Coullet等。报告了2例角度支持的晶状体人工晶状体(pIOL)植入后2年严重的内皮细胞丢失的情况。第一名患者在植入时为47岁,第二名患者为52岁。此外,在第二种情况下,术前内皮细胞计数(ECC)为2000细胞/ mm〜2,这是大多数类型的pIOL植入的下限。通过双凸透镜方法进行屈光手术的比例正在增加。外科医生必须通过植入pIOL来告知患者有关保留晶状体的风险和益处,而不是屈光镜更换(RLE)和IOL放置的替代方案。在第二种情况下,关于伪适应,多焦点和不利的视觉效果的各种IOL选项随后进行了进一步的讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号